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Abstract—We tested whether trans fatty acids and saturated fatty acids had different effects on flow-mediated vasodilation
(FMD), a risk marker of coronary heart disease (CHD). Consumption of trans fatty acids is related to increased risk of
CHD, probably through effects on lipoproteins. Trans fatty acids differ from most saturated fatty acids because they
decrease serum high-density lipoprotein (HDL) cholesterol, and this may increase the risk of CHD. We fed 29 volunteers
2 controlled diets in a 234-week randomized crossover design. The “Trans-diet” contained 9.2 energy percent of trans
fatty acids; these were replaced by saturated fatty acids in the “Sat-diet.” Mean serum HDL cholesterol after the
Trans-diet was 0.39 mmol/L (14.8 mg/dL), or 21% lower than after the Sat-diet (95% CI 0.28 to 0.50 mmol/L). Serum
low density lipoprotein and triglyceride concentrations were stable. FMD1SD was 4.462.3% after the Trans-diet and
6.263.0% after the Sat-diet (difference 21.8%, 95% CI 23.2 to 20.4). Replacement of dietary saturated fatty acids by
trans fatty acids impaired FMD of the brachial artery, which suggests increased risk of CHD. Further studies are needed
to test whether the decrease in serum HDL cholesterol caused the impairment of FMD. (Arterioscler Thromb Vasc Biol.
2001;21:1233-1237.)
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When liquid oils are partially hydrogenated to form solidmargarines and shortenings, trans isomers of fatty
acids are formed. In countries such as the United States1,2 and
the Netherlands,3 trans fatty acids (TFAs) constitute 4% to
7% of dietary fat intake. A high intake of TFAs is associated
with an increased risk of coronary heart disease (CHD).4–6
One probable cause is the effect of TFAs on serum lipopro-
teins. Like saturated fatty acids, TFAs increase the concen-
tration of serum LDL cholesterol.7,8 Moreover, and unlike
saturated fatty acids, TFAs decrease serum HDL cholesterol
(HDL-C).7–11 This might be harmful, inasmuch as there is
increasing evidence that HDL-C is inversely related to
CHD.12,13
We investigated whether the intake of trans fat would
indeed increase the risk of CHD more than the intake of
saturated fat by comparing the effects of these fats on
endothelial function, a surrogate cardiovascular end
point.14–16 We assessed endothelial function as flow-mediated
vasodilation (FMD) of the brachial artery, because this is a
noninvasive measurement that correlates well with known
risk factors17–22 and other markers of CHD.23–25 Moreover, 2
longitudinal studies show an association between FMD in the
past with future CHD events.26,27 The diets were given for a
minimum of 3 weeks, a time period long enough to establish
changes in serum lipids28 and FMD.21 We hypothesized that
FMD would be lower after the diet rich in trans fat than after
the diet rich in saturated fat because of the expected differ-
ence in serum HDL-C.
Methods
Subjects
The Medical Ethical Committee of Wageningen University approved
the study aim and design. Each volunteer signed an informed consent
form. We recruited 39 nonsmoking men and women and assessed
their health by using a questionnaire; we eliminated 1 person because
of use of medication, 2 because of missing information, and 1
because of poor veins for venipuncture. All subjects had normal
concentrations of serum cholesterol and triglycerides and normal
amounts of protein and glucose in their urine. We excluded 2
subjects because we could not obtain clear ultrasound images of their
brachial arteries. One other subject withdrew before the start of the
study; in the end, 32 subjects were enrolled. They all completed the
study.
Study Design
We provided 2 controlled diets for 4 weeks, each in a randomized
crossover design. The diets consisted of conventional food items
supplemented with special margarines and were given in a 28-day
menu cycle. On Mondays through Fridays, subjects came to our
dining room and ate a hot meal under our supervision. All other
foods (bread; margarine; meat and/or cheese; honey, jam, or sprin-
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kles; fruit; milk and/or yogurt) were packed for consumption at
home, as was food for the weekends.
Habitual energy intake of the subjects was estimated from a
food-frequency questionnaire. We designed menus for 14 levels of
energy intake, ranging from 7 to 20 MJ/d, and allocated the subjects
to an intake level close to their habitual energy intake. We provided
90% of energy (en%); all this food was weighed out for each subject.
We measured body weight twice a week; if body weight changed .1
kg, subjects were switched to a different energy intake level. The
remaining 10 en% had to be chosen from a list of low-fat food items
and recorded in a diary. Subjects received the diets for 21 to 32 days
(mean 27.5 days).
Diets
The experimental diets differed in margarine only (Table 1). The
composition of the diets was calculated by using food composition
tables3,29,30 and checked by collecting duplicates of all meals (Table
2). The analyzed values were similar to the calculated composition.
The margarine in the diet rich in TFAs (Trans-diet) was a blend of
70 parts partially hydrogenated soy oil, containing 44% trans-C18:1
(Gouda’s Glorie, Van Dijk Foods), 14 parts vegetable oil containing
63% linoleic acid and 23% oleic acid (Becel, Unilever), and 16 parts
water. The margarine in the diet rich in saturated fat (Sat-diet) was
a blend of 60 parts palm kernel fat (Loders Croklaan) and 40 parts
commercially available margarine made from a blend of vegetable
oils and solid vegetable fats (Blue Band, Van den Bergh BV). Both
margarines were produced at NIZO Food Research. The margarines
were used as shortenings in bread and cookies, in sauce and gravy,
and as a spread. They supplied 62% of fat in the diets; the remaining
38% was mainly derived from meat, cheese and other dairy products,
eggs, and salad dressings.
Blood Lipids
We took blood samples after an overnight fast on 2 separate days
after day 19 of each diet. All 4 blood samples of each subject were
analyzed in duplicate within 1 run. Total cholesterol and triglycer-
ides (Cholesterol Flex and Triglycerides Flex reagent cartridge, Dade
Behring) and HDL-C (Liquid N-geneous HDL-C assay, Instruche-
mie BV) were measured, and LDL cholesterol was calculated with
the Friedewald formula. The coefficient of variation of 64 duplicate
measurements was 0.4% for total cholesterol, 1.5% for triglycerides,
and 1.1% for HDL-C.
Brachial Artery Measurements
All subjects had an overnight fast of at least 12 hours before the
measurements. We measured FMD of the brachial artery as de-
scribed by Celermajer et al22 and Sorensen et al.31 We used the
diameter of the artery at rest and at maximum vasodilation to
calculate the percentage increase or FMD. All measurements were
performed at end diastole by the use of the R wave of the ECG. The
ultrasound images were made by 1 technician with a 7.5-MHz linear
array transducer of an Ultramark 9 HDI duplex scanner. All images
were stored on super-VHS videotapes for offline analysis.
Subjects were made to lie down in a temperature-controlled room
(range 20°C to 23°C) with the right arm in 2 arm support cushions.
An inflatable cuff was placed around the lower arm. The transducer
was held in position at the site of the antecubital crease with a
specially developed transducer arm holder (method developed by R.
Meijer’s group, Vascular Imaging Center, The Julius Center for
Patient Oriented Research UMC, Utrecht, the Netherlands).
We first obtained an optimal 2D B-mode ultrasound image of the
brachial artery at rest and recorded 3 images to measure the diameter.
We then inflated the cuff to 250 mm Hg and kept this pressure
constant for 5 minutes to induce ischemia in the forearm and hand.
After 5 minutes, the cuff was deflated. The image of the brachial
artery was optimized, and changes in the diameter of the artery were
recorded during the next 5 minutes. Every 15 seconds, a frozen
image was stored on videotape. At the end of the second feeding
period, we also measured endothelium-independent vasodilation
after a sublingual dose of 400 mg of nitroglycerin.
One reader who was blinded to the treatment read all the images
at the Vascular Imaging Center of the University Medical Center in
Utrecht. The reader rated the quality of the images from class 1
(perfect) to class 4 (unfit for use). All 32 subjects were measured
twice on both diets, so we had 4 measurements per subject. Of these
128 measurements, 24 were rated as perfect, 71 as fair, 26 as
marginal, and 2 as unfit. Five measurements were missing. We used
only measurements that were rated perfect or fair, which left us with
29 subjects for whom we had observations on both diets. At a mean
FMD of 5.3% of the resting diameter, the SD within subjects was
2.6% points, so the corresponding coefficient of variation was 49%.
The largest difference in a duplicate FMD measurement was 18.2%
TABLE 1. Fatty Acid Composition of Margarines Used in Diet
Rich in TFAs and Diet Rich in Saturated Fatty Acids
Fatty Acid
Margarine, g/100 g Fatty Acid
Trans-Diet Sat-Diet
Saturated 30.5 63.1
Lauric acid (C12:0) ND 24.5
Myristic acid (C14:0) 0.1 10.2
Palmitic acid (C16:0) 10.5 17.0
Stearic acid (C18:0) 18.5 7.4
Cis-Monounsaturated 18.6 20.9
Oleic acid (cis-C18:1n-9) 8.0 19.9
Trans-Monounsaturated 41.4 0.6
Trans-C18:1 40.9* 0.3
Polyunsaturated 8.7 15.0
Linoleic acid (cis,cis-C18:2) 8.2 14.6
Others 1.3 0.6
ND indicates not detected.
*Mainly n-10 (22%), n-9 (20%), and n-11 (17%) isomers.
TABLE 2. Analyzed Composition of the 2 Experimental Diets
Fatty Acid Trans-Diet Sat-Diet
Carbohydrate, en% 48.6 45.6
Protein, en% 14.0 13.5
Total fat, en% 37.4 41.0
Saturated 12.9 22.9
Lauric acid (C12:0) 0.3 6.8
Myristic acid (C14:0) 0.8 3.8
Palmitic acid (C16:0) 5.7 7.8
Stearic acid (C18:0) 5.3 3.1
Monounsaturated, total 18.2 8.8
Cis-C18:1 8.4 7.9
Trans-C18:1 9.2 0.3
Total trans 9.4 0.4
Polyunsaturated 4.7 6.9
Linoleic acid (cis,cis-C18:2) 4.1 5.9
Linolenic acid (cis,cis,cis-C18:3) 0.3 0.7
Cholesterol
mg/MJ 27.0 26.8
mg/d 248.4 253.5
Fiber
g/MJ 3.2 3.1
g/d 29.4 29.3
Energy
MJ/d 9.20 9.46
kcal/d 2199 2261
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points (FMD 2.6% and 20.8% of the resting diameter); the smallest
difference was 0.16% points (measurements were 7.2% and 7.4% of
the resting diameter). The coefficient of variation of the resting and
maximum diameter was 8%.
Statistical Analysis
We averaged the duplicate measurements in each dietary period and
tested for order effects by ANOVA, with diet and order as main
effects in the model.32 Because the order of the 2 diets did not
significantly contribute to the model, we then calculated for each
subject the difference between treatments. We tested whether these
differences were significantly different from zero by the Student t
test for paired samples. We give 2-sided 95% CIs for the differences.
Results
We analyzed the data of 29 subjects (10 men and 19 women). Their
mean (6SD) age was 30616 years, their mean weight was 6969
kg, and their mean body mass index was 22.562.4 kg/m2. Prestudy
serum cholesterol concentrations were 5.161.1 mmol/L, and serum
triglycerides were 1.260.7 mmol/L.
Body Weight
During the 4-week feeding periods, body weight remained
basically stable, with mean decreases of 0.4 kg during the
Trans-diet and 0.6 kg during the Sat-diet (P50.43 for
difference in change between diets).
Blood Lipids
Serum HDL-C decreased from 1.8760.46 mmol/L
(73.1617.8 mg/dL) on the diet rich in saturated fats to
1.4960.33 mmol/L (56.5612.8 mg/dL) on the diet rich in
trans fats (Table 3). The decrease was 0.39 mmol/L (95% CI
20.50 to 20.28), or 21%. Serum LDL cholesterol and
triglycerides remained stable. The order of the 2 diets hardly
affected the change in HDL-C: the mean change was
0.3560.25 mmol/L in subjects who went from the Trans-diet
to the Sat-diet and 0.4360.32 mmol/L in the subjects who
received the diets in the reverse order.
Brachial Artery Measurements
The diameter of the brachial artery at rest was 4.0260.70 mm
on the Sat-diet and 4.0860.73 mm on the Trans-diet. The
maximum diameter was 4.3360.80 mm on the Sat-diet and
4.1960.73 mm on the Trans-diet. FMD was 6.263.0% on the
Sat-diet and 4.462.3% on the Trans-diet (P50.015). Thus,
FMD was 1.8% (95% CI 23.2 to 20.4), or 29% lower on the
Trans-diet than on the Sat-diet (Figure). The order of the 2
diets hardly affected the results: 15 subjects went from an
FMD of 4.8% after the Trans-diet to 6.4% after the Sat-diet,
whereas 14 other subjects went from 5.9% after the Sat-diet
to 4.2% after the Trans-diet.
All subjects showed vasodilation after nitroglycerin (range
4.4% to 20.8%). Diet had no effect on nitroglycerin-mediated
vasodilation, which was 14.363.4% on the Trans-diet and
13.465.3% on the Sat-diet (unpaired t test, P50.64).
A decrease in HDL-C went together with a decrease in
FMD in 18 of 29 subjects. The correlation between changes
in HDL-C and FMD was positive (r50.12, 95% CI 20.26 to
0.46) but not significant (P50.55).
Discussion
Consumption of TFAs resulted in lower HDL-C and a smaller
FMD than consumption of saturated fatty acids. This might
explain the increased risk of cardiovascular disease at high
intakes of TFAs. However, whether the impaired vasodilation
was attributable to the decrease in HDL-C remains to be
determined.
HDL-C, Other Dietary Factors, and
Endothelial Function
There is some evidence that changes in HDL-C concentration
could change endothelial function. First, higher serum
HDL-C is associated with better endothelial function.24,33,34
This might be due to the proposed antioxidant capacity of
HDL,35 which might prevent oxidation of LDL and therefore
prevent adverse effects of oxidatively modified LDL on
endothelial function. We know of no other interventions
aimed at HDL, but other antioxidants, such as vitamin C,36,37
were shown to improve FMD. Second, there is ample
evidence that reductions in other known risk factors, such as
LDL cholesterol21,25,38 or homocysteine,39 improve FMD,
suggesting that changes in HDL-C could have similar effects.
The fact that we did not find a significant correlation between
changes in HDL-C and FMD does not rule out a causal
relation, because the data were too scarce to correct for
possible confounding variables, such as sex and age. On the
other hand, a significant correlation would be no proof of a
causal relation.
Other factors in the diets might account for the effect on
FMD. As shown in Table 2, there was a small difference in
linoleic acid between the 2 diets, and studies with rats show
that TFAs have stronger effects at low intakes of linoleic
acid.40 Although this might apply to humans, those rat studies
were performed at very high intakes of TFAs (20 en%), and
the adverse effects could be counteracted with a linoleic acid
intake as low as 2 en%. Thus, the 4.1 en% provided by
linoleic acid in our 9.2 en% Trans-diet was not low compared
TABLE 3. Concentration of Serum Lipids After 4-wk
Consumption of the 2 Diets
Trans-Diet Sat-Diet
Difference
(95% CI)
Total cholesterol, mmol/L 4.9760.94 5.3460.95 20.37 (20.24–20.50)
HDLs, mmol/L 1.4860.33 1.8760.45 20.39 (20.28–20.50)
LDLs, mmol/L 3.0460.80 3.0560.81 20.01 (20.14–0.11)
Triglycerides, mmol/L 0.9860.41 0.9060.36 0.08 (20.04–0.20)
Values are mean6SD. The 29 subjects consumed both diets for 4 weeks in
random order. To convert values for total, HDL, and LDL cholesterol to
milligrams per deciliter, multiply by 38.67. To convert triglycerides to milli-
grams per deciliter, multiply by 88.54.
FMD of the 29 subjects after the diet rich in TFAs (solid
squares) and after the diet rich in saturated fatty acids (open
squares). The subjects consumed both diets for 21 to 32 days
in randomized order.
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with percentages in the rat studies. Also, we think that the
difference in linoleic acid between the Sat-diet and Trans-diet
was too small to fully explain the effects seen on FMD.
Another factor is vitamin E; the different fat mixtures likely
differed by 10 to 20 mg/100 g. However, studies that showed
an effect of vitamin E on FMD41 used much higher doses, and
even at these high doses, most studies did not show an
effect.42–44 Last, FMD is impaired in diabetes,45 and if TFAs
and saturated fatty acids have different effects on insulin
metabolism, this could have biased the results. However, it is
unlikely that fasting serum insulin was different between the
2 diets.46
We do not know of studies that compared long-term effects
of different fats on FMD. Postprandial effects of saturated
and cis-monounsaturated fats seem to be similar; they all
appear to impair FMD compared with preprandial values or
compared with low-fat control meals.36,47,48 However, some
of these studies36,47 are flawed because the low-fat meals had
a higher vitamin C content than the fat-enriched meals, which
might have improved FMD.49 We know of no short-term
effects of TFAs on FMD.
Study Limitations
We used a crossover design to eliminate variation due to
differences between subjects. The order of the 2 diets was
balanced and randomized per subject to eliminate bias due to
a systematic drift of the outcome variables over time.32
Although we did not include a washout period, we did not
find a significant order effect on any of the blood lipoproteins
or for FMD.
We were interested only in differences between the 2 test
diets but not in changes from the habitual diet; therefore, no
baseline data were collected. We can only speculate on
changes in blood lipoproteins and FMD from baseline. Both
experimental diets differed in fat content from habitual diets:
the amount of TFAs in the Trans-diet was ’23 g/d, which is
5-fold higher than the estimated 4.8 g/d for men and 3.8 g/d
for women in the Netherlands.3 The amount of saturated fat in
the Sat-diet was 58 g/d, which is also higher than the habitual
intake of 42 g/d for men and 32 g/d for women in the
Netherlands. Because of the low habitual intake of TFAs,
replacing them all by saturated fatty acids would probably
hardly improve endothelial function. Conversely, our find-
ings imply that replacing all saturated fatty acids by TFAs
could impair FMD and should therefore be discouraged.
The inclusion of women in the present study may have
increased the variation in FMD response, because changes in
serum estradiol concentrations affect FMD.50 However, we
minimized this variation with 4-week study periods, the
length of a menstrual cycle. Compared with the men, the
women appeared to respond stronger to the diets, with a 2.3
percentage-unit (95% CI 0.4 to 4.2) smaller FMD on the
Trans-diet than on the Sat-diet; in the men, the difference was
0.8 percentage units (95% CI 21.3 to 3.0). However, the
number of men was small (n510); therefore, the present
study was not powered to test for sex differences. Further
studies with larger numbers of men and women are needed to
test for differences in response.
Repeatability of the FMD Measurement
We found a mean FMD of 5.3%. This is somewhat lower than
values for healthy volunteers reported by others,16,36,50 but
differences in methodology (eg, the position of the inflatable
cuff)51 could account for this. The variability in FMD was
high; we found a coefficient of variation of 49%. This is
comparable with the variability found in some studies52,53 but
higher than values reported by others.23,31,50,54,55 However, in
most studies it is unclear how the values for variability have
been calculated.
In conclusion, we showed that replacement of saturated
fatty acids by TFAs in the diet lowered serum HDL-C and
impaired FMD. This suggests that TFAs increase the risk of
CHD more than the intake of saturated fats, with similar
effects on LDL cholesterol. Further studies are needed to
verify whether decreases in HDL-C indeed impair endothelial
function and thereby explain the increased risk of CHD at
high intakes of trans fats.
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